Physician belief in the art of medicine is running up against the challenge of costs being shifted to patients and health systems and the desire of payers to have less variation in care, said Derek Raghavan, MD, PhD, FACP, FRACP, president, Carolinas HealthCare System's Levine Cancer Institute.
Physician belief in the art of medicine is running up against the challenge of costs being shifted to patients and health systems and the desire of payers to have less variation in care, said Derek Raghavan, MD, PhD, FACP, FRACP, president, Carolinas HealthCare System's Levine Cancer Institute.
Transcript
What are the culture challenges that make it difficult for health systems and practices to implement evidence-based guidelines?
It's becoming increasingly challenging to structure our approach to medicine, and there are a whole bunch of issues that get in the way. I think the first, and most important one, is the territorial imperative of the physician. Most physicians like to be independent, they believe in the art of medicine; they feel there is a nuance that will be available with their own personal skill. And, to be truthful, there is something to be said for that. The art of medicine is important. The more experienced physician is going to be, probably, better than the less experienced physician. Part of the difficulty is that some of the art of medicine is predicated on opinion rather than fact.
The second issue that is very challenging at the moment is the fact that we can no longer provide the medical care that we have traditionally with the money that's available to support it. Costs are being shifted to patients; costs are being shifted to healthcare systems. So there's a tension that is driven by that. The people who pay for healthcare—whether it's governments or health insurance funds—are looking for less variation and more structure and a bigger evidence base.
There has been a symposium at the American Society of Hematology meeting focused on the use of guidelines and how to disperse those guidelines into clinical practice, thinking about the impediments to the use of guidelines by physicians.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More